Literature DB >> 15692198

Transient non-autoimmune fetal heart block.

Johannes M P J Breur1, Martijn A Oudijk, Philip Stoutenbeek, Gerard H A Visser, Erik J Meijboom.   

Abstract

OBJECTIVES: Fetal heart block is a rare and irreversible condition associated with structural heart defects or maternal autoantibodies (SS-A/Ro and SS-B/La) resulting in permanent damage of the atrioventricular (AV) node. This is the first report of 4 cases with a transient fetal heart block in structurally normal hearts without maternal autoantibodies.
METHODS: A report on 4 patients seen within a 14-year period at one center with fetal heart block without intracardiac abnormalities or maternal autoantibodies.
RESULTS: Three patients were referred to our center with a fetal bradycardia (heart rate 70-85 bpm), between 20 and 33 weeks' gestational age, and 1 for a 'triple' test at 16 weeks' gestational age. Echocardiography showed a complete heart block in 2 fetuses, and a second-degree AV block in the other 2. Heart block had completely resolved at all following visits. Postnatal ECG recordings showed normal sinus rhythm in all patients. Echocardiographic evaluation at presentation and follow-up showed normal cardiac anatomy, without signs of hydrops or cardiac decompensation in all patients. All mothers tested negative on SS-A/Ro and SS-B/La autoantibodies.
CONCLUSIONS: Fetal heart block can occur in the absence of structural heart defects and maternal autoantibodies to SS-A/Ro and SS-B/La. The origin of such heart block is unknown, but its course seems benign: none of the patients ever showed ventricular heart rates <55 bpm, signs of congestive heart failure or fetal hydrops. Heart block resolved spontaneously in all patients. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15692198     DOI: 10.1159/000082427

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

1.  Doppler fetal mechanical PR interval prolongation with positive maternal anti-RNP but negative SSA/Ro and SSB/La auto-antibodies.

Authors:  Ruben J Acherman; Deborah M Friedman; Jill P Buyon; Joel Schwartz; William J Castillo; Robert C Rollins; William N Evans
Journal:  Prenat Diagn       Date:  2010-08       Impact factor: 3.050

2.  Congenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive cases.

Authors:  Antonio Brucato; Chiara Grava; Maria Bortolati; Keigo Ikeda; Ornella Milanesi; Rolando Cimaz; Veronique Ramoni; Gabriele Vignati; Stefano Martinelli; Youcef Sadou; Adele Borghi; Angela Tincani; Edward K L Chan; Amelia Ruffatti
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

3.  Remission of congenital complete heart block without anti-Ro/La antibodies: A case report.

Authors:  Souvik Mitra; Anindya Kumar Saha; Syamal Kumar Sardar; Arun Kumarendu Singh
Journal:  Ann Pediatr Cardiol       Date:  2013-07

4.  Spontaneous Remission of Congenital Complete Atrioventricular Block in Anti-Ro/La Antibody-Negative Monozygotic Twins: Case Report.

Authors:  Taner Kasar; Murat Saygı; İsa Özyılmaz; Yakup Ergül
Journal:  Balkan Med J       Date:  2017-01-05       Impact factor: 2.021

5.  Brazilian Fetal Cardiology Guidelines - 2019.

Authors:  Simone R F Fontes Pedra; Paulo Zielinsky; Cristiane Nogueira Binotto; Cristiane Nunes Martins; Eduardo Sérgio Valério Borges da Fonseca; Isabel Cristina Britto Guimarães; Izabele Vian da Silveira Corrêa; Karla Luiza Matos Pedrosa; Lilian Maria Lopes; Luiz Henrique Soares Nicoloso; Marcia Ferreira Alves Barberato; Marina Maccagnano Zamith
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

6.  Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment.

Authors:  Wadi Mawad; Lisa Hornberger; Bettina Cuneo; Marie-Josée Raboisson; Anita J Moon-Grady; Jane Lougheed; Karim Diab; Julia Parkman; Earl Silverman; Edgar Jaeggi
Journal:  J Am Heart Assoc       Date:  2022-01-08       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.